4,100 Shares in Kenvue Inc. $KVUE Acquired by Traub Capital Management LLC

Traub Capital Management LLC purchased a new stake in shares of Kenvue Inc. (NYSE:KVUE) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 4,100 shares of the company’s stock, valued at approximately $86,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Trust Co. of Vermont boosted its holdings in shares of Kenvue by 266.8% during the 2nd quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock worth $33,000 after buying an additional 1,150 shares during the period. Truvestments Capital LLC bought a new position in Kenvue in the 1st quarter valued at about $37,000. Clal Insurance Enterprises Holdings Ltd lifted its position in Kenvue by 378.5% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company’s stock worth $39,000 after acquiring an additional 1,287 shares during the last quarter. Bank Julius Baer & Co. Ltd Zurich boosted its holdings in shares of Kenvue by 120.6% during the first quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,699 shares of the company’s stock worth $41,000 after acquiring an additional 929 shares during the period. Finally, First Pacific Financial bought a new stake in shares of Kenvue during the second quarter worth approximately $54,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on KVUE shares. JPMorgan Chase & Co. reduced their price target on Kenvue from $24.00 to $21.00 and set an “overweight” rating for the company in a research note on Friday, October 10th. Edward Jones downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a report on Monday, November 3rd. Royal Bank Of Canada reduced their target price on shares of Kenvue from $24.00 to $22.00 and set a “sector perform” rating for the company in a research report on Friday, August 8th. Evercore ISI set a $18.00 price target on shares of Kenvue in a research report on Tuesday, October 28th. Finally, Bank of America decreased their target price on shares of Kenvue from $25.00 to $21.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, twelve have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $20.23.

Kenvue Price Performance

Shares of NYSE:KVUE opened at $16.08 on Thursday. The firm has a 50 day moving average of $16.27 and a 200-day moving average of $19.90. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $30.80 billion, a PE ratio of 21.43, a PEG ratio of 2.25 and a beta of 0.71.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.83 billion. During the same period last year, the firm posted $0.28 earnings per share. The firm’s quarterly revenue was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, equities research analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 26th. Investors of record on Wednesday, November 12th will be paid a $0.2075 dividend. The ex-dividend date of this dividend is Wednesday, November 12th. This represents a $0.83 annualized dividend and a yield of 5.2%. Kenvue’s dividend payout ratio (DPR) is 110.67%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.